Stay updated on Low-Dose Cytarabine/Azacitidine+Venetoclax+Quizartinib in AML Clinical Trial
Sign up to get notified when there's something new on the Low-Dose Cytarabine/Azacitidine+Venetoclax+Quizartinib in AML Clinical Trial page.

Latest updates to the Low-Dose Cytarabine/Azacitidine+Venetoclax+Quizartinib in AML Clinical Trial page
- Check7 days agoChange DetectedThe history shows an addition of Revision: v3.5.0 and a deletion of Revision: v3.4.3.SummaryDifference0.1%

- Check14 days agoChange DetectedA new revision entry, v3.4.3, was added to the record history and the previous revision, v3.4.2, was removed. This is an administrative update to the page's version history.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check29 days agoNo Change Detected
- Check43 days agoChange DetectedThe record history shows the addition of revision v3.4.2 and removal of v3.4.1. This is a metadata update to the page with no changes to study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check50 days agoChange DetectedThe record history now includes a new revision entry v3.4.1 and removes v3.4.0, reflecting a system site update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check57 days agoChange DetectedGlossary toggle and color-coded change highlights (green for additions, red for deletions) were added, along with a new Revision: v3.4.0 label; the No FEAR Act data text and the Revision: v3.3.4 entry were removed.SummaryDifference1%

- Check72 days agoChange DetectedNew revision v3.3.4 added to the Record History; the previous revision v3.3.3 is shown in the history.SummaryDifference0.1%

Stay in the know with updates to Low-Dose Cytarabine/Azacitidine+Venetoclax+Quizartinib in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Low-Dose Cytarabine/Azacitidine+Venetoclax+Quizartinib in AML Clinical Trial page.